Construction of a Nomogram for Lymphovascular Invasion or Ductal Involvement in Node‐Negative Superficial Esophageal Squamous Cell Carcinoma
Journal of Gastroenterology and Hepatology · 2026-03 · 41 (3) · 979-991
DOI: 10.1111/jgh.70237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 15.01.2026. Verfasst von Chun-Xiao Yue und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Nomograms, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Early esophageal cancer is prone to lymphovascular invasion (LVI) and ductal involvement (DI), which seriously affects the prognosis of patients. Therefore, identifying the potential risk factors for LVI/DI is crucial. This study aims to clarify endoscopic appearances which are predictive for LVI/DI in patients with node‐negative superficial esophageal squamous cell carcinoma (SESCC).
Methods
A total of 401 lesions were included for model development. Endoscopic image features were selected through multivariate logistic regression and LASSO (least absolute shrinkage and selection operator) regression analysis, and the optimal model was determined by calculating cNRI (continuous net reclassification improvement) and IDI (integrated discrimination improvement). Additionally, internal and external validation were performed using data from 173 and 133 lesions, respectively.
Results
Five endoscopic image features, including lesion length, macroscopic type, surface granularity, surface nodularity, and surface erosion, were identified as predictive factors and were incorporated into the nomogram. The nomogram demonstrated substantial predictive efficacy, as evidenced by the AUC (area under curve) values of 0.854 (95% CI: 0.809–0.899) for the training set, 0.821 (95% CI: 0.749–0.894) for the internal validation set, and 0.860 (95% CI: 0.765–0.955) for the external validation set. Calibration curves showed good agreement between the nomogram predictions and actual observations. DCA (decision curve analysis) and CICs (clinical impact curves) confirmed the nomogram's clinical applicability.
Conclusions
We constructed a nomogram based on preoperative endoscopic image features for predicting the risks of LVI/DI in patients with node‐negative SESCC, which may aid in clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
- Department of Pathology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
ORCID-Profile: Ya-Dong Feng
Zitieren
APA
Yue, C. X., Liang, Y., Wei, X. Y., Liang, Y. M., Bai, X. Y., Zhu, A. J., Huang, S. J., Zhou, Y., & Feng, Y. D. (2026). Construction of a Nomogram for Lymphovascular Invasion or Ductal Involvement in Node‐Negative Superficial Esophageal Squamous Cell Carcinoma. Journal of Gastroenterology and Hepatology, 41(3), 979-991. https://doi.org/10.1111/jgh.70237
Vancouver
Yue CX, Liang Y, Wei XY, Liang YM, Bai XY, Zhu AJ, et al. Construction of a Nomogram for Lymphovascular Invasion or Ductal Involvement in Node‐Negative Superficial Esophageal Squamous Cell Carcinoma. Journal of Gastroenterology and Hepatology. 2026;41(3):979-991. doi:10.1111/jgh.70237
BibTeX
@article{Yue2026,
author = {Yue, Chun-Xiao and Liang, Yan and Wei, Xiao-Ying and Liang, Yi-Min and Bai, Xiao-Yu and Zhu, Ai-Jing and Huang, Shuai-Jing and Zhou, Yang and Feng, Ya-Dong},
title = {Construction of a Nomogram for Lymphovascular Invasion or Ductal Involvement in Node‐Negative Superficial Esophageal Squamous Cell Carcinoma},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {3},
pages = {979--991},
doi = {10.1111/jgh.70237}
}
EUVIMED